Found 205 matching trials
SGLT2 Inhibitors in Geographic Atrophy PHASE2 AMD is a leading cause of blindness in individuals over 50 years old, with ...
Show More Location
Washington University
Learn More & Join Trial
A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients PHASE4 This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Show More Learn More & Join Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. PHASE3 This is an international, multicentre, parallel-group, event-driven, random...
Show More Learn More & Join Trial
Dapagliflozin (DAPA) Effects in HFpEF PHASE2 The purpose of this study is to determine whether treatment with Dapagliflo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients PHASE2 The purpose of this study is to obtain information on efficacy and safety o...
Show More Learn More & Join Trial
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD PHASE3 the effect of Dapagliflozin on erythropoiesis, iron metabolism and inflamma...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. PHASE4 SGLT2 antagonists and GLP1 agonists are used since a relatively short perio...
Show More Location
Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III
Learn More & Join Trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care PHASE3 Background Acute Kidney Injury (AKI) is a potentially life-threatening cond...
Show More Learn More & Join Trial
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients PHASE3 This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Show More Location
Diabeteszentrum Oldenburg
Learn More & Join Trial
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone PHASE3 The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Show More Location
Local Institution
Learn More & Join Trial